Dr. Daniel Salerno, MD
Claim this profileTemple University
Studies Tuberculosis
Studies Mycobacterium Avium Complex Infection
2 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Daniel Salerno, MD is currently running
Antibiotic Therapy
for Mycobacterium Avium Complex Infection
NTM therapy consists of a multi-drug macrolide based regimen for 18-24 months. Treated patients frequently experience debilitating side effects, and many patients delay the start of antibiotic treatment due to these risks. Common side effects include nausea, diarrhea, and fatigue, and rare but serious toxicities include ocular toxicity, hearing loss, and hematologic toxicity. To date, most of the evidence underlying the current treatment recommendations has come from observational studies in which either a macrolide has been combined with rifampin and ethambutol, or in some cases combined with ethambutol alone. The proposed study will answer whether a third drug is necessary or whether taking two drugs can increase tolerability without a substantial loss of efficacy.
Recruiting1 award Phase 2 & 33 criteria
Clofazimine
for Mycobacterium Avium Complex Infection
The purpose of this study is to evaluate the clinical effectiveness and safety of clofazimine when used to treat Mycobacteria avium complex (MAC) lung disease. Funding Source - FDA OOPD
Recruiting0 awards Phase 2
More about Daniel Salerno, MD
Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Daniel Salerno, MD has experience with
- Clofazimine
- Azithromycin
- Ethambutol
- Rifampin
Breakdown of trials Daniel Salerno, MD has run
Tuberculosis
Mycobacterium Avium Complex Infection
Nontuberculous Mycobacterial Infections
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Salerno, MD specialize in?
Daniel Salerno, MD focuses on Tuberculosis and Mycobacterium Avium Complex Infection. In particular, much of their work with Tuberculosis has involved treating patients, or patients who are undergoing treatment.
Is Daniel Salerno, MD currently recruiting for clinical trials?
Yes, Daniel Salerno, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Daniel Salerno, MD has studied deeply?
Yes, Daniel Salerno, MD has studied treatments such as Clofazimine, Azithromycin, Ethambutol.
What is the best way to schedule an appointment with Daniel Salerno, MD?
Apply for one of the trials that Daniel Salerno, MD is conducting.
What is the office address of Daniel Salerno, MD?
The office of Daniel Salerno, MD is located at: Temple University, Philadelphia, Pennsylvania 19140 United States. This is the address for their practice at the Temple University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.